Form EFFECT AVADEL PHARMACEUTICALS

February 17, 2026 6:19 AM EST
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 13, 2026
Accession Number: 0001104659-26-014343
Submission Type: POS AM
CIK: 0001012477
Company Name: AVADEL PHARMACEUTICALS PLC
File Number: 333-237962


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings